Recent achievements in the area of studying biological activity of new natural compounds toward thioredoxin reductase 1 (TrxR1) are considered. The most important chemotypes of the compounds exhibiting activity toward TrxR1 were revealed. The pharmacophoric environment of the electron-deficient olefin group that possesses a chemical potential for covalent inhibiting to TrxR1 was examined.